Maternal Vaccination Shows Strong Efficacy Against Infant RSV

New real-world research suggests that vaccinating during pregnancy provides substantial protection for newborns against severe Respiratory Syncytial Virus (RSV). The study found approximately 68-69% effectiveness in preventing RSV-related hospitalizations and severe pulmonary infections in infants under three months old. This development offers encouraging news for infant health.